Intestinal cell response to bacterial apoptotic signals

肠细胞对细菌凋亡信号的反应

基本信息

  • 批准号:
    7350883
  • 负责人:
  • 金额:
    $ 30.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-02-01 至 2012-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In recent years there has been an increasing interest in the interactions between bacteria and eukaryotic hosts. This interest is targeted largely at understanding mechanisms of infectious disease, but the study of host-microbe interactions are also likely to be highly relevant to understanding many aspects of normal physiology. Nowhere are these interactions as important as in the human gut, which is subject to a wide variety of infections that affect it directly. Microbe-host interactions often result in inflammatory responses, and bacteria themselves play a central role in modulating this tissue response. A related process is apoptosis or programmed cell death. Apoptosis is the intrinsic self-elimination of individual cells and is a common reaction to bacterial infection. Interestingly, this tightly regulated process shares many of the biochemical signaling pathways as do proinflammatory responses, and inflammatory effector genes exert intricate and tight regulatory influences on apoptosis, suggesting that a component of the inflammatory response is necessary to control apoptotic activation. Eukaryotic cells monitor the presence of bacterial products or PAMPs (pathogen associated molecular patterns) by a conserved family of "pattern-recognition receptors" such as the Toll-like receptors, that are capable of activating proinflammatory pathways. In this proposal, our overarching hypothesis is that pattern recognition receptors are able to activate cytoprotective/anti-apoptotic programs during bacterial infection/colonization. We have been studying the flagellin/Toll-like receptor 5 as a candidate PAMP/TLR pair. We have shown that aflagellate Salmonella typhimurium do not activate significant proinflammatory responses in epithelia, however, they do result in increased apoptosis in vitro and increased tissue injury in vivo. We hypothesize that bacterial flagellin, recognized via the cellular pattern recognition receptor TLR5, activates anti-apoptotic/survival genes as an intrinsic and inseparable aspect of the inflammatory response. We will utilize a variety of biochemical, microbiological, tissue culture and murine systems to study the mechanisms and consequences of how epithelial cells regulate apoptosis induced by Salmonella. These studies will increase our understanding of the pathogenesis of enteric bacterial infections, and possibly illuminate means by which commensal bacteria contribute to the health of the Gl tract.
描述(由申请人提供):近年来,人们对细菌和真核宿主之间的相互作用越来越感兴趣。这种兴趣主要是针对理解感染性疾病的机制,但宿主-微生物相互作用的研究也可能与理解正常生理学的许多方面高度相关。这些相互作用在人类肠道中的重要性无处不在,人类肠道受到各种直接影响它的感染。微生物-宿主相互作用通常导致炎症反应,而细菌本身在调节这种组织反应中起着核心作用。一个相关的过程是细胞凋亡或程序性细胞死亡。细胞凋亡是单个细胞的内在自我消除,是细菌感染的常见反应。有趣的是,这种严格调控的过程与促炎反应一样共享许多生化信号传导途径,并且炎症效应基因对细胞凋亡施加复杂和严格的调控影响,这表明炎症反应的一个组分是控制细胞凋亡激活所必需的。真核细胞通过保守的“模式识别受体”家族(如Toll样受体)监测细菌产物或PAMP(病原体相关分子模式)的存在,这些受体能够激活促炎途径。在这个提议中,我们的首要假设是模式识别受体能够在细菌感染/定植期间激活细胞保护/抗凋亡程序。我们一直在研究鞭毛蛋白/Toll样受体5作为候选PAMP/TLR对。我们已经表明,aflagellate鼠伤寒沙门氏菌不激活显着的促炎反应上皮细胞,但是,他们确实导致增加细胞凋亡在体外和增加组织损伤在体内。我们假设,细菌鞭毛蛋白,通过细胞模式识别受体TLR 5识别,激活抗凋亡/生存基因作为一个内在的和不可分割的方面的炎症反应。我们将利用各种生化,微生物,组织培养和小鼠系统来研究上皮细胞如何调节沙门氏菌诱导的细胞凋亡的机制和后果。这些研究将增加我们对肠道细菌感染的发病机理的理解,并可能阐明肠道细菌有助于胃肠道健康的方式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew S Neish其他文献

Multi-Center Clinical Validation of a Mass Spectrometry Immunoassay for the Diagnosis and Monitoring of Multiple Myeloma and Associated Disorders
  • DOI:
    10.1182/blood-2023-189050
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Oscar Berlanga;Jane Birtwistle;Syreeta Allen;Gemma Malin;Cristina Simion;Habib El-Khoury;Julia Colchie;Luca Bertamini;Grace Fleming;Erica M. Horowitz;Irene M. Ghobrial;Kaleb B McLendon;John Roback;Andrew S Neish;Sarah K Grewal;Gabriella Lakos
  • 通讯作者:
    Gabriella Lakos

Andrew S Neish的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew S Neish', 18)}}的其他基金

Immune Monitoring Core
免疫监测核心
  • 批准号:
    10680630
  • 财政年份:
    2020
  • 资助金额:
    $ 30.74万
  • 项目类别:
Role of Gut Inflammation and Immunity on Proteostasis, Noradrenergic Degeneration and AD risk
肠道炎症和免疫对蛋白质稳态、去甲肾上腺素能变性和 AD 风险的作用
  • 批准号:
    10139341
  • 财政年份:
    2020
  • 资助金额:
    $ 30.74万
  • 项目类别:
Immune Monitoring Core
免疫监测核心
  • 批准号:
    10222319
  • 财政年份:
    2020
  • 资助金额:
    $ 30.74万
  • 项目类别:
Intestinal cell response to bacterial apoptotic signals
肠细胞对细菌凋亡信号的反应
  • 批准号:
    7564067
  • 财政年份:
    2007
  • 资助金额:
    $ 30.74万
  • 项目类别:
Intestinal cell response to bacterial apoptotic signals
肠细胞对细菌凋亡信号的反应
  • 批准号:
    8037214
  • 财政年份:
    2007
  • 资助金额:
    $ 30.74万
  • 项目类别:
Intestinal cell response to bacterial apoptotic signals
肠细胞对细菌凋亡信号的反应
  • 批准号:
    7211965
  • 财政年份:
    2007
  • 资助金额:
    $ 30.74万
  • 项目类别:
Epithelial specific ubiquitination events
上皮特异性泛素化事件
  • 批准号:
    9010902
  • 财政年份:
    2006
  • 资助金额:
    $ 30.74万
  • 项目类别:
Epithelial specific ubiquitination events
上皮特异性泛素化事件
  • 批准号:
    8322949
  • 财政年份:
    2006
  • 资助金额:
    $ 30.74万
  • 项目类别:
Epithelial specific ubiquitination events
上皮特异性泛素化事件
  • 批准号:
    7142202
  • 财政年份:
    2006
  • 资助金额:
    $ 30.74万
  • 项目类别:
Epithelial specific ubiquitination events
上皮特异性泛素化事件
  • 批准号:
    8627106
  • 财政年份:
    2006
  • 资助金额:
    $ 30.74万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 30.74万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 30.74万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 30.74万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 30.74万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 30.74万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 30.74万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 30.74万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 30.74万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 30.74万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 30.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了